story of the week
Disease Reactivation After Teprotumumab Treatment for Active Thyroid Eye Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
American Journal of Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Reactivation after teprotumumab treatment for active thyroid eye disease
Am J Ophthalmol 2023 Dec 22;[EPub Ahead of Print], CJ Hwang, NP Rebollo, KB Mechels, JD PerryFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.